16-07-12 Serendex Pharmaceuticals A/S : Minutes of Serendex’s Extraordinary General Meeting 2016 PU
16-06-21 Serendex Pharmaceuticals A/S : Savara Pharmaceuticals acquires Serendex PU
16-05-25 Serendex Pharmaceuticals A/S : First patient dosed in Serendex’s pivotal trial for PAP PU
16-05-12 Serendex Pharmaceuticals A/S : signs license agreement with Japanese partner PU
16-05-02 Serendex Pharmaceuticals A/S : Delisting of Serendex as of 4 May 2016 PU
16-04-29 Serendex Pharmaceuticals A/S : Minutes of Serendex’s Ordinary General Meeting 2016 PU
16-04-28 Serendex Pharmaceuticals A/S : Brief Account of Serendex’s Ordinary General Meeting PU
16-04-04 Serendex Pharmaceuticals A/S : releases Annual Report 2015 PU
16-03-08 Serendex Pharmaceuticals A/S : secures credit facility PU
16-03-07 Serendex Pharmaceuticals A/S : to delist from Oslo Axess; to terminate market making agreement with NORNE A/S PU
16-02-19 Serendex Pharmaceuticals A/S : pivotal clinical trial for PAP approved in Japan PU
16-02-19 Serendex Pharmaceuticals A/S : Correction to Serendex Financial Calendar 2016 PU
16-02-10 Serendex Pharmaceuticals A/S : Correction to Serendex Financial Calendar 2016 PU
16-02-10 Serendex Pharmaceuticals A/S : Minutes from Serendex’s Extraordinary General Meeting PU
16-02-09 Serendex Pharmaceuticals A/S : Brief Account of Serendex’s Extraordinary General Meeting PU
16-01-28 Serendex Pharmaceuticals A/S : establishes a warrant programme for the company’s employees PU
16-01-25 Serendex Pharmaceuticals A/S : Extraordinary General Meeting – correction to “The Complete Proposals” PU
16-01-13 Serendex Pharmaceuticals A/S : New share capital registered – correction of previously announced result of the issue PU
16-01-06 Serendex Pharmaceuticals A/S : Primary insider notification PU
16-01-06 Serendex Pharmaceuticals A/S : The Rights Issue in Serendex Pharmaceuticals A/S was fully subscribed PU
16-01-06 Serendex Pharmaceuticals A/S : Major shareholding notification PU
15-12-18 Serendex Pharmaceuticals A/S : to potentially enter into license agreement with strategic partner for Japan PU
15-12-10 Serendex Pharmaceuticals A/S : Rights issue – record date information PU
15-12-10 Serendex Pharmaceuticals A/S : Strategic review and future financing PU
15-12-03 Serendex Pharmaceuticals A/S : Primary insider notification PU
No results match your criteria
  1. Stock Market
  2. Stocks
  3. SENDEX Stock
  4. News Serendex Pharmaceuticals A/S